Epidermal Growth Factor Receptor Is Related to Poor Survival in Glioblastomas: Single-Institution Experience

키워드

참고문헌 (37)

1. Wallner KE, "Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma", Int J Radiat Oncol Biol Phys, 16, pp.1405~1409 (1989)
2. Andersen AP, "Postoperative irradiation of glioblastomas. Results in a randomized series", Acta Radiol Oncol Radiat Phys Biol, 17, pp.475~484 (1978)
3. Walker MD, "Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery", N Engl J Med, 303, pp.1323~1329 (1980)
4. Kocher M, "Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma", Strahlenther Onkol, 184, pp.572~579 (2008)
5. Stupp R, "Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial", Lancet Oncol, 10, pp.459~466 (2009)
6. Nicholas MK, "Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas", Clin Cancer Res, 12, pp.7261~7270 (2006)
7. Fuller GN, "Amplified cellular oncogenes in neoplasms of the human central nervous system", Mutat Res, 276, pp.299~306 (1992)
8. Libermann TA, "Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin", Nature, 313, pp.144~147 (1985)
9. Wong AJ, "Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification", Proc Natl Acad Sci U S A, 84, pp.6899~6903 (1987)
10. Salomon DS, "Epidermal growth factor-related peptides and their receptors in human malignancies", Crit Rev Oncol Hematol, 19, pp.183~232 (1995)
11. Waha A, "Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas", J Neurosurg, 85, pp.634~641 (1996)
12. Etienne MC, "Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome", Clin Cancer Res, 4, pp.2383~2390 (1998)
13. Ruano Y, "Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration", Am J Clin Pathol, 131, pp.257~263 (2009)
14. Shinojima N, "Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme", Cancer Res, 63, pp.6962~6970 (2003)
15. Smith JS, "PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme", J Natl Cancer Inst, 93, pp.1246~1256 (2001)
16. Simmons ML, "Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients", Cancer Res, 61, pp.1122~1128 (2001)
17. Zhu A, "Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation", Int J Radiat Oncol Biol Phys, 34, pp.809~815 (1996)
18. Chakravarti A, "Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group", Int J Radiat Oncol Biol Phys, 62, pp.318~327 (2005)
19. Bouvier-Labit C, "Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas", Neuropathol Appl Neurobiol, 24, pp.381~388 (1998)
20. Donato V, "Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide", Tumori, 93, pp.248~256 (2007)
21. Galanis E, "Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas", Int J Oncol, 13, pp.717~724 (1998)
22. Newcomb EW, "Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes", Brain Pathol, 8, pp.655~667 (1998)
23. Quan AL, "Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme", Int J Radiat Oncol Biol Phys, 63, pp.695~703 (2005)
24. Viana-Pereira M, "Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas", Anticancer Res, 28, pp.913~920 (2008)
25. Atkins D, "Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections", J Histochem Cytochem, 52, pp.893~901 (2004)
26. Derecskei K, "Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissues", Pathol Oncol Res, 12, pp.243~246 (2006)
27. Kersting C, "Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas", J Clin Pathol, 59, pp.585~590 (2006)
28. Langner C, "Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?", J Clin Pathol, 57, pp.773~775 (2004)
29. Nelson DF, "Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401", ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group, 1988, pp.(6), 279~284
30. Souhami L, "Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol", Int J Radiat Oncol Biol Phys, 60, pp.853~860 (2004)
31. Tsien C, "Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03", Int J Radiat Oncol Biol Phys, 73, pp.699~708 (2009)
32. Simpson JR, "Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials", Int J Radiat Oncol Biol Phys, 26, pp.239~244 (1993)
33. Kowalczuk A, "Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas", Neurosurgery, 41, pp.1028~1036 (1997)
34. Sandberg-Wollheim M, "A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and", or 4, 1991, pp.68, 22~29
35. Lacroix M, "A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival", J Neurosurg, 95, pp.190~198 (2001)
36. Lamborn KR, "Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis", Neuro Oncol, 6, pp.227~235 (2004)
37. Li J, "Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma", Int J Radiat Oncol Biol Phys, 81, pp.623~630 (2011)

관련 논문AI추천